Brain surgery bleeding breakthrough? drug may cut blood loss
NCT ID NCT06229483
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if a drug called tranexamic acid (TXA) can reduce blood loss during brain tumor surgery. About 102 adults having a craniotomy will receive either TXA or a placebo. Researchers will measure blood loss and check for bleeding-related complications within 30 days after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nova Scotia Health Authority- Queen Elizabeth II Health Sciences Center
RECRUITINGHalifax, Nova Scotia, B3H3A7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- A cup of lavender tea a day may keep PMS blues away — science puts it to the test
- Digital tests may offer a new way to track brain health in tumor patients
- Mapping the hidden toll of brain radiation on young minds
- Scientists create detailed brain maps to protect language during surgery
- Could a cancer drug shrink recurrent brain tumors?